While clearly informative for understanding aspects of FSHD pathology and testing therapeutics aimed to reduce the effects of DUX4, is “exogenous” DUX4 modelling FSHD, or a novel mouse “DUX4opathy”? Here, DUX4 is linked to Facioscapulohumeral dystrophy.